Vimarsana
Biggest News Aggregation in the World

Page 12 - Resented News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Resented. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Resented Today - Breaking & Trending Today

Cantargia publishes ASCO 2023 poster on promising nadunolimab efficacy in non-small cell lung cancer - Vimarsana News

Cantargia publishes ASCO 2023 poster on promising nadunolimab efficacy in non-small cell lung cancer

Cantargia today presented interim efficacy data for 39 non-small cell lung cancer patients treated with nadunolimab and platinum-based chemotherapy as a poster at the ASCO Annual Meeting 2023 , and... | June 4, 2023

BE OPEN Foundation: BE OPEN presented SDG-focused student competition programme at the World Climate Industry EXPO in Busan, Korea - Vimarsana News

BE OPEN Foundation: BE OPEN presented SDG-focused student competition programme at the World Climate Industry EXPO in Busan, Korea

LONDON, June 2, 2023 /PRNewswire/ -- The World Climate Industry EXPO in Busan became a great opportunity for BE OPEN to present its SDG-focused programme and in particular the ongoing student

BE OPEN presented SDG-focused student competition programme at the World Climate Industry EXPO in Busan, Korea - Vimarsana News

BE OPEN presented SDG-focused student competition programme at the World Climate Industry EXPO in Busan, Korea

PRNewswire

InMed Pharmaceuticals: InMed's Neurodegenerative Disease Study Presented at Canadian Neuroscience Meeting - Vimarsana News

InMed Pharmaceuticals: InMed's Neurodegenerative Disease Study Presented at Canadian Neuroscience Meeting

Vancouver, British Columbia--(Newsfile Corp. - June 1, 2023) - InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a leader in the pharmaceutical research, development, manufacturing

Biovica International: DiviTum TKa Results to be Presented at ASCO - Vimarsana News

Biovica International: DiviTum TKa Results to be Presented at ASCO

UPPSALA, SE / ACCESSWIRE / June 1, 2023 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) Biovica, active in cancer diagnostics, today announces that a poster with DiviTum® TKa results from